Bharat Biotech’s Covaxin Was 50 Percent Effective in Real-World Study

By PacConAdmin | November 24, 2021

India-based Bharat Biotech’s COVID-19 vaccine, Covaxin (BBV152), was just 50 percent effective in preventing infections among hospital employees in India who received the recommended two doses.
Source: Drug Industry Daily

Posted in Drug Industry Daily